Kezar Life Sciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
08 Oct 24 | Buy€5,514,566 | Kevin Tang | Individual | 720,000 | €7.66 | |
02 Jul 24 | Sell€3,613 | Mark Schiller | Individual | 668.8 | €5.40 |
Insider Trading Volume
Insider Buying: 2KZ0 insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
VC/PE Firms | 625,455 | 8.57% |
Individual Insiders | 907,352 | 12.4% |
Hedge Funds | 1,219,359 | 16.7% |
General Public | 1,624,632 | 22.3% |
Institutions | 2,919,424 | 40% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
720,000 | €5.2m | 0% | no data | |||
716,759 | €5.2m | 0% | 0.2% | |||
625,455 | €4.5m | 0% | 100.0% | |||
502,600 | €3.6m | 0% | 0.21% | |||
382,736 | €2.8m | 0% | 0.03% | |||
274,110 | €2.0m | 0% | no data | |||
251,177 | €1.8m | 42.6% | 0.33% | |||
194,799 | €1.4m | 0% | 0.33% | |||
192,700 | €1.4m | 0% | 0.02% | |||
157,712 | €1.1m | -15% | no data | |||
149,130 | €1.1m | 42% | 0.38% | |||
140,290 | €1.0m | 13.4% | no data | |||
133,827 | €963.9k | 23.2% | 0.18% | |||
129,707 | €934.2k | 66.6% | no data | |||
122,752 | €884.1k | 24.4% | 0.27% | |||
106,899 | €769.9k | 23% | 0.23% | |||
90,176 | €649.5k | -21.5% | no data | |||
89,069 | €641.5k | 0% | no data | |||
82,871 | €596.9k | 0% | 0.04% | |||
82,857 | €596.8k | -0.22% | no data | |||
62,691 | €451.5k | 15% | no data | |||
49,422 | €355.9k | -21.4% | no data | |||
43,612 | €314.1k | 0% | no data | |||
43,135 | €310.7k | 0% | no data | |||
29,777 | €214.5k | -69.4% | no data |